用户验证的应用
推荐稀释比例
- IHC-P1/100 Boil tissue section in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at room temperature for 20 min. Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- Flow Cyt1/1000 ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
详细信息
背景信息
Product Specifications Anti-CD8 alpha antibody [SP16] (ab101500) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cyt, IHC-P in human samples. Anti-CD8 alpha antibody [SP16] (ab101500) specifically detects CD8 alpha (UniProt ID: P01732; Molecular weight: 24kDa) and is sold in 100 µL, 500 µL and 1 mL selling sizes. Quality and Validation Anti-CD8 alpha antibody [SP16] (ab101500) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC). Abcam's high quality manufacturing and validation processes ensure Anti-CD8 alpha antibody [SP16] (ab101500) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-CD8 alpha antibody [SP16] (ab101500) has been cited over 53 times in peer reviewed journals and is trusted by the scientific community. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (77)
A Robust Immunohistochemistry-Based Classification for BRAF V600E-Mutant Colorectal Cancer With Clinical Implications.
基于免疫组织化学的BRAF V600E突变型结直肠癌的稳健分类及其临床意义。
Plac1(+) Tumor Cell-Treg Interplay Supports Tumorigenesis and Progression of Head and Neck Cancer.
Place1(+)肿瘤细胞-Treg相互作用支持头颈癌的肿瘤发生和进展
ACAT1 regulates tertiary lymphoid structures and correlates with immunotherapy response in non-small cell lung cancer.
ACAT1 调节三级淋巴结构，并与非小细胞肺癌的免疫治疗反应相关
PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion
PCK1通过消耗GTP抑制cGAS-STING活化，从而促进肿瘤免疫逃逸。
Mature tertiary lymphoid structures support B cell-mediated antitumour immunity and are disrupted by neoadjuvant therapy in rectal cancer: a multicentre, retrospective study.
成熟的三级淋巴结构支持 B 细胞介导的抗肿瘤免疫，但在直肠癌新辅助治疗中受到破坏：一项多中心回顾性研究。
Multiomics Reveals the Immunologic Features and the Immune Checkpoint Blockade Potential of Colorectal Medullary Carcinoma
多组学揭示结直肠髓样癌的免疫学特征和免疫检查点阻断潜力
DPP7 promotes fatty acid β-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer
DPP7促进肿瘤相关巨噬细胞中的脂肪酸β-氧化，并决定结直肠癌的免疫抑制微环境。
Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer.
确定成人和儿童脑癌靶向免疫治疗的细胞外基质
Development and validation of prognostic model based on distribution and density of CD3(+) and CD8(+) infiltrating lymphocytes in breast cancer: A multicenter cohort study.
基于乳腺癌中 CD3(+) 和 CD8(+) 浸润淋巴细胞的分布和密度的预后模型的开发和验证：一项多中心队列研究。
Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.
肿瘤侵袭防御指数——预测 II-III 期结直肠癌复发和生存的新指标
- 1
- 2
- 3
- 4
- 5
- 6
- 8